HAEHaemonetics Corporation
Is it safe?
Forensics clean, with a caveat: a safe balance sheet and clean books, but big price swings.
Financially healthy, low distress risk Altman Z-score, a bankruptcy-risk model from five balance-sheet ratios.
Reported earnings show no manipulation flags Beneish M-score, a forensic model that detects earnings-manipulation patterns (receivables outrunning sales, margins slipping, accrual-heavy profit).
High fundamental quality Piotroski F-score, nine pass/fail tests of year-over-year financial health across profitability, balance sheet and efficiency. 7 to 9 is strong, 0 to 3 weak.
Investment-grade balance sheet. A rule of thumb on leverage, not a credit rating.
Large price swings, high volatility. Worst drawdown -69% · now at/near its 52-week high.
Unless marked, from SEC EDGAR, as of Mar 28, 2026.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.
Can HAE take a bad year?
Haemonetics Corporation carries $951M of net debt at 3.52× EBITDA: a load its earnings can carry.
Net debt · as at Q1 2027 · between two and four years of EBITDA, normal for a stable business
- Net debt / EBITDA
- 3.52×
Net debt / EBITDA · 2.65× a year ago · the load is going up
- Altman Z-score
- 2.54
Altman Z-score · grey zone, between 1.8 and 3
- Debt / equity
- 1.40×
Debt / equity
Details›
- Total debtQ1 2027
- $1.17B
- Cash and short-term investments
- $223M
- Net debt
- $951M
- EBITDA, trailing twelve months
- $270M
- Operating profit, trailing twelve months
- $160M
- Debt / equity
- 1.40×
- Total debt / EBITDA
- 4.34×
- Annualised volatilitytwo years of daily moves
- 48%
- Worst drawdown on file
- −69%
- Below its 52-week high
- 0.72%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.